TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ROIV

Roivant Sciences Ltd

Healthcare · Biotechnology

36.10$ -1.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ROIV
Line item 2019 2020 2021 2022 2023 2024 2025 2026
– – – – – – – –
– – +0.0% +0.0% +217.9% +16.9% -36.1% -76.2%
– +108.2% -30.7% +565.0% -61.5% -8.3% +44.8% +19.8%
– – – +50.9% +24.1% – – –
– -69.2% +370.3% -78.1% -59.6% +200.0% -504.8% –
– -56.9% +18.1% +200.3% -27.2% -89.1% +232.8% +78.5%
– – -101.9% – -114.6% – -133.9% -61.4%
– – – – – -96.3% – –
– +16,014.8% -100.0% – – +200.9% -136,086.5% -75.3%
– -70.6% -71.4% +0.0% +776.1% -123.7% +71.8% -100.0%
– -71.7% +110.1% -32.8% +62.8% -16.0% -390.9% –
– +19.4% -109.5% – – – -178.7% –
– – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?